GRAPHIC-The great exit: central banks line up to dial back emergency stimulus msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
10 Biggest Companies and Hedge Funds Bullish on Ethereum
Crypto stocks have plummeted in value over the past week amid inflation worries, social media speculation, and Chinese restrictions on financial institutions that facilitate cryptocurrency transactions. Bitcoin, the most popular cryptocurrency, has dropped more than 26% in the last seven days, leading to a chain reaction that has affected other stocks that mine blockchain as well. However, amid all the chaos and volatility surrounding crypto in the recent past, Ethereum, the second most popular cryptocurrency in the world, has performed surprisingly well.
Big companies like Tesla, Inc. (NASDAQ: TSLA) and Alphabet Inc. (NASDAQ: GOOG) have turned bullish on Ethereum after noticing the steps it is taking to become environmentally stable. Ethereum is in the process of reducing reliance on energy intensive mining. Tesla, Inc. (NASDAQ: TSLA) owner Elon Musk earlier this month suspended Bitcoin payments at his firm citing environm
10 Biggest Companies and Hedge Funds Bullish on Ethereum yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Global investors swoop in on WuXi Biologics shares as owner trims stakes in worlds largest post-IPO disposals WuXi Biologics, China site. Photo: Handout
WuXi Biologics (Cayman), a bellwether of China s pharmaceutical producers, kicked off 2021 this week with a record stock price that took its gains since its 2017 initial public offer to 14-fold.
Nearly 142 million shares changed hands on Tuesday, almost triple the average daily transactions last year, led by a 2.5 per cent sell-down that formed part of the disposal programme by the company s controlling shareholder Biologics Holdings from 73.5 per cent in 2017 to 20.6 per cent.
Waiting in the wings to pick up Biologics shares were institutional investors including JPMorgan Chase, Morgan Stanley and the Los Angeles-based private investment manager Capital Group, said Daiwa Capital Markets analyst Dennis Ip.